PRESS RELEASES

View and download our latest press releases, sorted by date. For any information request, please send it directly to us via the contact form.

Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment

aortic stenosis, niut, ultrasound, valvosoft

June 16, 2026

June 16 2026 Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Cardiawave_PR_First_treatments_aortic_Stenosis_15…

VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking

aortic stenosis, niut, ultrasound, valvosoft

December 4, 2025

04/12/2025 VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking Cardiawave_PR CE Mark Valvosoft 2025-12-04Download …

VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE

aortic stenosis, niut, ultrasound, valvosoft

December 4, 2025

04/12/2025 VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE Cardiawave_PR CE Mark Valvosoft 202…

Search

PRESS RELEASES

PRESS RELEASES

Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment

VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking

VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE

l Latest news

l Our social networks

l Contact Us